• 
  Priscilla Leon, Geraldine Cancel-Tassin, Violaine Bourdon, Bruno Buecher, Stephane Oudard, et al.. Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer. Prostate, Wiley, 2021, ⟨10.1002/pros.24109⟩. ⟨hal-03153082⟩
• 
  Joseph Ciccolini, Dominique Barbolosi, Nicolas André, Sebastien Benzekry, Fabrice Barlesi. Combinatorial immunotherapy strategies: most gods throw dice, but fate. Annals of Oncology, Elsevier, 2019, 30 (11), pp.1690-1691. ⟨10.1093/annonc/mdz297/5559268⟩. ⟨hal-03147132⟩
• 
  Joseph Ciccolini, Sébastien Benzekry, Fabrice Barlesi. Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects. British Journal of Cancer, Cancer Research UK, 2020, 123 (3), pp.337-338. ⟨10.1038/s41416-020-0918-3⟩. ⟨hal-03147110⟩
• 
  Joseph Ciccolini, Dominique Barbolosi, Nicolas André, Fabrice Barlesi, Sébastien Benzekry. Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators?. JCO Precision Oncology, 2020, 108 (4), pp.486-491. ⟨10.1200/PO.19.00381⟩. ⟨hal-03147084⟩
• 
  Maria Teresa Borrello, Patricia Santofimia-Castaño, Marco Bocchio, Angela Listi, Nicolas Fraunhoffer, et al.. NUPR1 interacts with eIF2α and is required for resolution of the ER stress response in pancreatic tissue. FEBS Journal, Wiley, 2021, ⟨10.1111/febs.15700⟩. ⟨hal-03129151⟩
• 
  Steven Le Gouill, Hervé Ghesquieres, Lucie Obéric, Franck Morschhauser, Herve Tilly, et al.. Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA. Blood, American Society of Hematology, 2020, ⟨10.1182/blood.2020008750⟩. ⟨hal-03122586⟩
• 
  Paulina Prorok, Marie Artufel, Antoine Aze, Philippe Coulombe, Isabelle Peiffer, et al.. Involvement of G-quadruplex regions in mammalian replication origin activity. Nature Communications, Nature Publishing Group, 2019, 10 (1), pp.3274. ⟨10.1038/s41467-019-11104-0⟩. ⟨hal-03101805⟩
• 
  A. Takedachi, E. Despras, S. Scaglione, R. Guérois, J. Guervilly, et al.. SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations. Nature Structural and Molecular Biology, Nature Publishing Group, 2020, 27 (5), pp.438-449. ⟨10.1038/s41594-020-0419-3⟩. ⟨hal-03079782⟩
• 
  Chris Planque, Fatemeh Rajabi, Fanny Grillet, Pascal Finetti, François Bertucci, et al.. Pregnane X-receptor promotes stem cell-mediated colon cancer relapse. Oncotarget, Impact journals, 2016, 7 (35), pp.56558-56573. ⟨10.18632/oncotarget.10646⟩. ⟨hal-01431926⟩
• 
  Fanny Grillet, Elsa Bayet, Olivia Villeronce, Luke Zappia, Ebba Louise Lagerqvist, et al.. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut, BMJ Publishing Group, 2017, 66 (10), pp.1802 - 1810. ⟨10.1136/gutjnl-2016-311447⟩. ⟨hal-01903677⟩
• 
  Pierre-Yves Salaun, Ronan Abgral, Olivier Malard, Solène Querellou-Lefranc, Gilles Quere, et al.. Good clinical practice recommendations for the use of PET/CT in oncology. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2020, 47 (1), pp.28-50. ⟨10.1007/s00259-019-04553-8⟩. ⟨hal-02489793⟩
• 
  Maud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, Amandine Crombe, Julien Adam, et al.. High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies. EBioMedicine, Elsevier, 2020, 62, ⟨10.1016/j.ebiom.2020.103131⟩. ⟨hal-03034609⟩
• 
  Catherine Uzan, Chafika Mazouni, Caroline Rossoni, Brigitte de Korvin, Christine Tunon de Lara, et al.. Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions. Annals of Surgical Oncology, Springer Verlag, 2020, ⟨10.1245/s10434-020-09107-z⟩. ⟨hal-03013819⟩
• 
  Sophie Vacher, Voreak Suybeng, Élodie Girard, Julien Masliah Planchon, Grégory Thomson, et al.. Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer. Cancers, MDPI, 2020, 12 (10), pp.2882. ⟨10.3390/cancers12102882⟩. ⟨hal-03011747⟩
• 
  Domitille Dano, Clémence Hénon, Ousseynou Sarr, Kanta Ka, Mouhamadou Ba, et al.. Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study. Journal of Global Oncology, 2019, 5 (5), pp.1-9. ⟨10.1200/JGO.19.00106⟩. ⟨inserm-03009567⟩
• 
  Constance Le Goux, Sophie Vacher, Anne Schnitzler, Nicolas Barry Delongchamps, Marc Zerbib, et al.. Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.16641. ⟨10.1038/s41598-020-73642-8⟩. ⟨hal-02986867⟩
• 
  Christian Pfister, Valentin Harter, Yves Allory, François Radvanyi, Stéphane Culine, et al.. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial. Contemporary Clinical Trials Communications, Elsevier, 2020, 17, pp.100536. ⟨10.1016/j.conctc.2020.100536⟩. ⟨hal-02909542⟩
• 
  Joachim Alexandre, Jennifer Cautela, Stéphane Ederhy, Ghandi Laurent Damaj, Joe-Elie Salem, et al.. Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines. Journal of the American Heart Association, Wiley-Blackwell, 2020, 9 (18), pp.e018403. ⟨10.1161/JAHA.120.018403⟩. ⟨hal-02949017⟩
• 
  A.V. Tallet, F. Dhermain, E. Le Rhun, G. Noël, Y.M. Kirova. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Annals of Oncology, Elsevier, 2017, 28 (12), pp.2962-2976. ⟨10.1093/annonc/mdx408⟩. ⟨inserm-02940523⟩
• 
  J. Lazarovici, P. Dartigues, P. Brice, L. Oberic, I. Gaillard, et al.. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study. Haematologica, Ferrata Storti Foundation, 2015, 100 (12), pp.1579-1586. ⟨10.3324/haematol.2015.133025⟩. ⟨inserm-02913989⟩

120

225